These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7892951)

  • 1. [Clinical-physiological characteristics and hormone therapy of patients with typical form of climacteric syndrome].
    Gudkova MA; Kulakov VI; Krymskaia ML; Solov'eva AD
    Akush Ginekol (Mosk); 1994; (6):49-52. PubMed ID: 7892951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical study comparing the effects of sequential hormone replacement therapy with oestradiol/dydrogesterone and conjugated equine oestrogen/norgestrel on lipids and symptoms.
    Cieraad D; Conradt C; Jesinger D; Bakowski M
    Arch Gynecol Obstet; 2006 May; 274(2):74-80. PubMed ID: 16491367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use.
    Marslew U; Munk-Nielsen N; Nilas L; Riis BJ; Christiansen C
    Maturitas; 1994 Oct; 19(3):225-37. PubMed ID: 7799829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estrogen metabolism and hormone substitution in the climacteric].
    Göretzlehner G; Kyank H
    Zentralbl Gynakol; 1985; 107(16):977-88. PubMed ID: 2996259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Climacteric disturbances. 2. Therapy of climacteric disturbances].
    Döring GK
    Fortschr Med; 1976 Jul; 94(19):1118-26. PubMed ID: 184019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Principles of hormone replacement therapy in climacteric].
    Smetnik VP
    Vestn Ross Akad Med Nauk; 1997; (2):34-8. PubMed ID: 9376728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Principles of replacement hormone therapy in climacteric disorders].
    Smetnik VP
    Akush Ginekol (Mosk); 1995; (3):15-7. PubMed ID: 7653720
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of estrogen supplementation on psychological variables in climacteric women].
    Gramegna G; Blümel JE; Jara S; Schiattino I; Lolas F
    Rev Med Chil; 1996 Oct; 124(10):1240-4. PubMed ID: 9239913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
    Marslew U; Overgaard K; Riis BJ; Christiansen C
    Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormonal therapy in perimenopause].
    Zaĭdieva IaZ
    Akush Ginekol (Mosk); 1995; (3):28-30. PubMed ID: 7653724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasomotor symptoms and estrogen-progestogen therapy.
    von Schoultz B
    Acta Obstet Gynecol Scand Suppl; 1985; 132():15-8. PubMed ID: 3161264
    [No Abstract]   [Full Text] [Related]  

  • 12. Progestogens: therapeutic and adverse effects in early post-menopausal women.
    Marslew U; Riis B; Christiansen C
    Maturitas; 1991 Mar; 13(1):7-16. PubMed ID: 1830636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Basic principles of hormone replacement therapy in the postmenopause].
    Dören M
    Ther Umsch; 2000 Oct; 57(10):628-34. PubMed ID: 11081374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of hormone replacement therapy on lipoprotein(a) and lipid levels in postmenopausal women. Influence of various progestogens and duration of therapy.
    Kim CJ; Min YK; Ryu WS; Kwak JW; Ryoo UH
    Arch Intern Med; 1996 Aug 12-26; 156(15):1693-700. PubMed ID: 8694668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug information: agents for the treatment of gynecologic diseases. Hormone substitution in the climacteric].
    Lumholtz IB
    Sygeplejersken; 1979 Sep; 79(38):10. PubMed ID: 229580
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparative study between estradiol valerate combined with cyproterone acetate, and conjugated equine estrogens combined with medroxyprogesterone acetate as hormone replacement therapy in climacteric].
    Carranza-Lira S; Martínez-Chéquer JC; Río de la Loza F; Murillo-Uribe A; Celis C
    Ginecol Obstet Mex; 2000 Nov; 68():442-7. PubMed ID: 11195956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Biweekly menopausal substitutive hormone therapy: effects on climacteric and prevention of osteoporosis].
    Zylberberg B; Dormont D
    Contracept Fertil Sex; 1996 Dec; 24(12):874-8. PubMed ID: 9026274
    [No Abstract]   [Full Text] [Related]  

  • 18. Bioidentical hormone replacement therapy. Customizing care for perimenopausal and menopausal women.
    Romero M
    Adv Nurse Pract; 2002 Nov; 10(11):47-8, 51-2. PubMed ID: 12478948
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hormonal adaptation in the climacteric and the question of hormone therapy in postmenopause].
    Kyank H
    Z Alternsforsch; 1966 Dec; 19(3):305-16. PubMed ID: 4294394
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversible busulfan-induced ovarian failure.
    Shalev O; Rahav G; Milwidsky A
    Eur J Obstet Gynecol Reprod Biol; 1987 Nov; 26(3):239-42. PubMed ID: 2828130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.